HomePharma

Pharma

Pharma

Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart

Life Sciences Times - 0
Pharma

Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis

Life Sciences Times - 0
Pharma

Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration

Life Sciences Times - 0
Pharma

Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease

Life Sciences Times - 0
Pharma

Zymeworks Reports Promising Early Data from Phase 1 Study of ZW191 Targeting Folate Receptor-Alpha in Advanced Solid Tumors

Life Sciences Times - 0
Pharma

Verastem Oncology Reports Promising Early Results from Ongoing Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor

Life Sciences Times - 0
Pharma

CDR-Life Reports Early Clinical Data Showing Pharmacodynamic Activity of CDR404 in MAGE-A4 Positive Solid Tumors

Life Sciences Times - 0
Pharma

FDA Grants Priority Review for KEYTRUDA and KEYTRUDA QLEX, Each in Combination with Padcev, for Certain Patients with Muscle-Invasive Bladder Cancer

Life Sciences Times - 0
Pharma

Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma

Life Sciences Times - 0
Pharma

USAntibiotics Receives FDA National Priority Voucher for Domestic Antibiotic Manufacturing

Life Sciences Times - 0
Pharma

IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial

Life Sciences Times - 0
Pharma

Parabilis Medicines Unveils Groundbreaking Clinical Data Showing First-Ever Drugging of Key Cancer Driver with FOG-001

Life Sciences Times - 0
1...8910...91Page 9 of 91

Most Read